Zomedica Stock News

Thanks to its cost-saving pet diagnostics platform, many investors are turning positive on Zomedica. Is now the time to strike with ZOM stock?

It could be a good growth pick, but it probably won't repeat its recent blastoff.

The market suddenly is paying more attention to valuation. That's a problem for ZOM stock, which looks drastically overvalued from any angle.

Nevertheless, with little reason for it to rally further, but with it still vulnerable to another move lower, skip out on ZOM stock, and look elsewhere for high-risk, but high-potential, opportunities

There's plenty and growing reasons off and on the price chart for ZOM stock investors to be appreciatively upbeat about. The post Why $5 in Zomedica Stock Looks Possible appeared first on InvestorPlac

TRUFORMA® Progressing Toward Commercialization TRUFORMA® Progressing Toward Commercialization

These seven meme stocks have been caught up in the short squeeze, and have grown immensely despite showing little promise from their fundamentals. The post 7 Meme Stocks That Have Retail Traders ‘St

This pet health company has made a few investors rich already, but more is still to come.

Both are highfliers with intriguing potential.

The prevailing logic as I see it is that the rising tide of the pet industry is going to float all boats, including ZOM stock. But the facts simply don't bear this out over the long term.

As Zomedica prepares to launch Truforma, its first commercial product, ZOM stock continues to experience volatility. The post Zomedica Stock Volatility Continues as Truforma Launch Nears appeared firs

There are heavy expectations for ZOM stock, even though Zomedica still has no revenues and a measured plan to roll out its Truforma device. The post It May Be Too Early to Believe in Zomedica Stock ap

Zomedica is a winner with its pet lab product and cash balance. ZOM stock is worth as much as $3.61 following its Truforma product launch.

ZOM stock has been on a tear this year, and is nearing the buy zone with the impending release of its Truforma Platform The post Zomedica Continues to Fly High With Its Recent Positive Developments ap

ZOM Stock has risen by more than 1,000% in the last three months as the launch of Truforma looms. However, Zomedica investors may in for a shocker.